Detalles de la búsqueda
1.
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
Clin Infect Dis
; 68(4): 535-544, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30184165
2.
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.
Gastroenterology
; 152(1): 164-175.e4, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27720838
3.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Lancet HIV
; 7(1): e16-e26, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740348
4.
Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women.
Am J Obstet Gynecol
; 198(3): 261.e1-11, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18313445
5.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
Lancet HIV
; 5(5): e211-e220, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29592840
6.
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Pediatr Infect Dis J
; 23(2): 132-7, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14872179
7.
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers.
Clin Cancer Res
; 20(22): 5672-85, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25239610
8.
Phase I trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma.
Clin Lymphoma Myeloma Leuk
; 12(5): 319-24, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23040438
9.
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.
J Clin Oncol
; 29(35): 4688-95, 2011 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22025163
10.
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
J Natl Cancer Inst
; 102(5): 325-39, 2010 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20139221
11.
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
J Infect Dis
; 199(7): 936-44, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236277
12.
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
J Infect Dis
; 199(7): 926-35, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236279
13.
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
Vaccine
; 26(52): 6844-51, 2008 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-18930097
14.
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
Vaccine
; 25(26): 4931-9, 2007 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-17499406
15.
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
Vaccine
; 24(27-28): 5571-83, 2006 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16753240
16.
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
Lancet Oncol
; 6(5): 271-8, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15863374
17.
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine.
Vaccine
; 22(21-22): 2936-42, 2004 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15246630
Resultados
1 -
17
de 17
1
Próxima >
>>